Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease

Toxicological Sciences

Volumn 120, Issue 1, 2011, Pages 68-78

  Benson, Jenna M ^a   Shepherd, David M ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Crohn's disease; Inflammation; Regulatory T cells

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENTERITIS; FEEDING; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE;

MURINAE; MUS;

EID: 79952096263     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq360     Document Type: Article

References (48)

1. Abraham, C., and Cho, J. H. (2009). IL-23 and autoimmunity: new insights intothe pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 60,97-110.
2. Aggarwal, B. B., and Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421.
3. Bankoti, J., Burnett, A., Navarro, S., Miller, A. K., Rase, B., and Shepherd, D. M. (2010a). Effects of TCDD on the fate of naive dendritic cells. Toxicol. Sci. 115, 422-434.
4. Bankoti, J., Rase, B., Simones, T., and Shepherd, D. M. (2010b). Functional and phenotypic effects of AhR activation in inflammatory dendritic cells. Toxicol. Appl. Pharmacol. 246, 18-28.
5. Baumgart, D. C., and Dignass, A. U. (2002). Intestinal barrier function. Curr. Opin. Clin. Nutr. Metab. Care 5, 685-694.
6. Belladonna, M. L., Grohmann, U., Guidetti, P., Volpi, C., Bianchi, R., Fioretti, M. C., Schwarcz, R., Fallarino, F., and Puccetti, P. (2006). Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in theabsence of functional IDO. J. Immunol. 177, 130-137.
7. Belladonna, M. L., Puccetti, P., Orabona, C., Fallarino, F., Vacca, C., Volpi, C., Gizzi, S., Pallotta, M. T., Fioretti, M. C., and Grohmann, U. (2007). Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. Transplantation 84, S17-S20.
8. Chirdo, F. G., Millington, O. R., Beacock-Sharp, H., and Mowat, A. M. (2005). Immunomodulatory dendritic cells in intestinal lamina propria. Eur. J. Immunol. 35, 1831-1840.
9. Cottart, C. H., Nivet-Antoine, V., Laguillier-Morizot, C., and Beaudeux, J. L. (2010). Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food Res. 54, 7-16.
10. Cui, X., Jin, Y., Hofseth, A. B., Pena, E., Habiger, J., Chumanevich, A., Poudyal, D., Nagarkatti, M., Nagarkatti, P. S., Singh, U. P., et al. (2010). Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev. Res. (Phila) 3, 549-559.
11. Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S., Durelli, I., et al. (2007). Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood 109, 2871-2877.
12. Denison, M. S., and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
13. Eastaff-Leung, N., Mabarrack, N., Barbour, A., Cummins, A., and Barry, S. (2010). Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J. Clin. Immunol. 30, 80-89.
14. Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., and Puccetti, P. (2002). T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9, 1069-1077.
15. Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006). The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176, 6752-6761.
16. Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., and Ferrara, G. B. (2002). Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196, 459-468.
17. Funatake, C. J., Ao, K., Suzuki, T., Murai, H., Yamamoto, M., Fujii-Kuriyama, Y., Kerkvliet, N. I., and Nohara, K. (2009). Expression of constitutively-active aryl hydrocarbon receptor in T-cells enhances the down-regulation of CD62L, but does not alter expression of CD25 or suppress the allogeneic CTL response. J. Immunotoxicol. 6, 194-203.
18. Funatake, C. J., Marshall, N. B., Steppan, L. B., Mourich, D. V., and Kerkvliet, N. I. (2005). Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells. J. Immunol. 175, 4184-4188.
19. Hartmann, G., Bidlingmaier, C., Siegmund, B., Albrich, S., Schulze, J., Tschoep, K., Eigler, A., Lehr, H. A., and Endres, S. (2000). Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J. Pharmacol. Exp. Ther. 292, 22-30.
20. Head, K., and Jurenka, J. S. (2004). Inflammatory bowel disease. Part II: Crohn's disease-pathophysiology and conventional and alternative treatment options. Altern. Med. Rev. 9, 360-401.
21. Ho, P. P., and Steinman, L. (2008). The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in disease. Cell Res. 18, 605-608.
22. Iwasaki, A., and Kelsall, B. L. (1999). Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229-239.
23. Kawada, M., Arihiro, A., and Mizoguchi, E. (2007). Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J. Gastroenterol. 13, 5581-5593.
24. Kim, Y. H., Kwon, H. S., Kim, D. H., Shin, E. K., Kang, Y. H., Park, J. H., Shin, H. K., and Kim, J. K. (2009). 3,3'-Diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflamm. Bowel Dis. 15, 1164-1173.
25. Larrosa, M., Yanez-Gascon, M. J., Selma, M. V., Gonzalez-Sarrias, A., Toti, S., Ceron, J. J., Tomas-Barberan, F., Dolara, P., and Espin, J. C. (2009). Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J. Agric. Food Chem. 57, 2211-2220.
26. Leibelt, D. A., Hedstrom, O. R., Fischer, K. A., Pereira, C. B., and Williams, D. E. (2003). Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3'-diindolylmethane in sprague-dawley rats. Toxicol. Sci. 74, 10-21.
27. Liu, Z., Colpaert, S., D'Haens, G. R., Kasran, A., de Boer, M., Rutgeerts, P., Geboes, K., and Ceuppens, J. L. (1999). Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J. Immunol. 163, 4049-4057.
28. Macpherson, A. J., and Uhr, T. (2004). Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662-1665.
29. Marshall, N. B., and Kerkvliet, N. I. (2010). Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann. N. Y. Acad. Sci. 1183, 25-37.
30. Marshall, N. B., Vorachek, W. R., Steppan, L. B., Mourich, D. V., and Kerkvliet, N. I. (2008). Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 181, 2382-2391.
31. Martin, A. R., Villegas, I., Sanchez-Hidalgo, M., and de la Lastra, C. A. (2006). The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br. J. Pharmacol. 147, 873-885.
32. Mellor, A. L., Chandler, P., Baban, B., Hansen, A. M., Marshall, B., Pihkala, J., Waldmann, H., Cobbold, S., Adams, E., and Munn, D. H. (2004). Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int. Immunol. 16, 1391-1401.
33. Monteleone, G., Biancone, L., Marasco, R., Morrone, G., Marasco, O., Luzza, F., and Pallone, F. (1997). Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112, 1169-1178.
34. Neurath, M. F., Fuss, I., Kelsall, B. L., Stuber, E., and Strober, W. (1995). Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182, 1281-1290.
35. Ng, L. G., Mackay, C. R., and Mackay, F. (2005). The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol. 42, 763-772.
36. Parronchi, P., Romagnani, P., Annunziato, F., Sampognaro, S., Becchio, A., Giannarini, L., Maggi, E., Pupilli, C., Tonelli, F., and Romagnani, S. (1997). Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150, 823-832.
37. Pizarro, T. T., Arseneau, K. O., Bamias, G., and Cominelli, F. (2003). Mouse models for the study of Crohn's disease. Trends Mol. Med. 9, 218-222.
38. Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., and Weiner, H. L. (2008). Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71.
39. Sanchez-Munoz, F., Dominguez-Lopez, A., and Yamamoto-Furusho, J. K. (2008). Role of cytokines in inflammatory bowel disease. World J. Gastroenterol. 14, 4280-4288.
40. Schmidt, J. V., and Bradfield, C. A. (1996). Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55-89.
41. Shepherd, D. M., Steppan, L. B., Hedstrom, O. R., and Kerkvliet, N. I. (2001). Anti-CD40 treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed C57Bl/6 mice induces activation of antigen presenting cells yet fails to overcome TCDD-induced suppression of allograft immunity. Toxicol. Appl. Pharmacol. 170, 10-22.
42. Takamura, T., Harama, D., Matsuoka, S., Shimokawa, N., Nakamura, Y., Okumura, K., Ogawa, H., Kitamura, M., and Nakao, A. (2010). Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol. Cell Biol. 88, 685-689.
43. Tas, S. W., Vervoordeldonk, M. J., Hajji, N., Schuitemaker, J. H., van der Sluijs, K. F., May, M. J., Ghosh, S., Kapsenberg, M. L., Tak, P. P., and de Jong, E. C. (2007). Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 110, 1540-1549.
44. Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H., and Opelz, G. (2002). Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447-457.
45. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C., and Stockinger, B. (2008). The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109.
46. Vogel, C. F., Goth, S. R., Dong, B., Pessah, I. N., and Matsumura, F. (2008). Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun. 375, 331-335.
47. Weigmann, B., Tubbe, I., Seidel, D., Nicolaev, A., Becker, C., and Neurath, M. F. (2007). Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2, 2307-2311.
48. Wirtz, S., Neufert, C., Weigmann, B., and Neurath, M. F. (2007). Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541-546.